You are required to be logged in to access the full website
Click here if you have forgotten your username or password
12 October 2026 - Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) on Monday announced positive topline results from the planned interim analysis of the Phase 3 ACTION-1 trial evaluating RYZ101, a radiopharmaceutical therapy developed by its...
12 October 2026 - Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) on Monday announced topline results from its Phase 3 ALOFT-IPF trial, which met its primary endpoint in evaluating admilparant in adults with idiopathic pulmonary fibrosis (I...
12 October 2026 - Swedish biopharmaceutical company Camurus AB (STO: CAMX) on Monday said it has received a Notice of Compliance from Health Canada for Oczyesa XR, a long-acting subcutaneous octreotide depot for adults with acromegaly who have respon...
12 October 2026 - ABL Texcell Diagnostics (Euronext Paris:ABLD), a provider of molecular biology tests, said on Monday that it has acquired IntegraGen's assets and business operations following a ruling by the Evry Commercial Court on 9 October ...
12 October 2026 - Danish biopharmaceutical company TETRAPHARM announced on Friday that it has appointed Rolf Sass Sorensen as its new chief executive officer.He succeeds Martin Rose, who founded the company along with Jesper Breum in 2018.This leader...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe